2. Academic Validation
  3. Pharmacokinetic Properties of Acetyl Tributyl Citrate, a Pharmaceutical Excipient

Pharmacokinetic Properties of Acetyl Tributyl Citrate, a Pharmaceutical Excipient

  • Pharmaceutics. 2018 Oct 8;10(4):177. doi: 10.3390/pharmaceutics10040177.
Hyeon Kim 1,  Min Sun Choi 2,  Young Seok Ji 3,  In Sook Kim 4,  Gi Beom Kim 5,  In Yong Bae 6,  Myung Chan Gye 7,  Hye Hyun Yoo 8
Affiliations

Affiliations

  • 1 Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. [email protected].
  • 2 Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. [email protected].
  • 3 Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. [email protected].
  • 4 Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. [email protected].
  • 5 Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. [email protected].
  • 6 Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. [email protected].
  • 7 Department of Life Science, Institute of Natural Sciences, Hanyang University, Seoul 04763, Korea. [email protected].
  • 8 Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. [email protected].
PMID: 30297635 DOI: 10.3390/pharmaceutics10040177
Abstract

Acetyl tributyl citrate (ATBC) is an (the Food and Drug Administration) FDA-approved substance for use as a pharmaceutical excipient. It is used in pharmaceutical coating of solid oral dosage forms such as coated tablets or capsules. However, the information of ATBC on its pharmacokinetics is limited. The aim of this study is to investigate the pharmacokinetic properties of ATBC using liquid chromatography⁻tandem mass spectrometric (LC⁻MS/MS) analysis. ATBC was rapidly absorbed and eliminated and the bioavailability was 27.4% in rats. The results of metabolic stability tests revealed that metabolic clearance may have accounted for a considerable portion of the total clearance of ATBC. These pharmacokinetic data would be useful in studies investigating the safety and toxicity of ATBC.

Keywords

acetyl tributyl citrate; metabolic stability; pharmaceutical excipient; pharmacokinetics; plasma.

Figures
Products